Beyond Bulls & Bears

Ozempic can’t help your overweight in big tech: Global ETF diversification ideas for 2024
ETFs

Ozempic can’t help your overweight in big tech: Global ETF diversification ideas for 2024

The start of a new year brings a chance for reflection and re-evaluation. For investors, a chance to rebalance. Franklin Templeton ETFs’ Dina Ting and Marcus Weyerer highlight the pitfalls of overweight exposure to mega tech stocks and where in the world to look for diversification in 2024.

The metaverse: A multi-decade opportunity
ETFs

The metaverse: A multi-decade opportunity

The metaverse—represented by immersive, shared online virtual worlds—has captured the attention not only of gamers, but also global enterprise across many industries. And it’s unlocking new investment opportunities, according to Dina Ting, Head of Global Index Portfolio Management, Franklin Templeton ETFs.